Skip to main content
. 2023 Jan 19;13:1028. doi: 10.1038/s41598-023-28242-7

Figure 2.

Figure 2

Overall survival and recurrence-free survival of clinical stage 0–IA patients according to status of lymph node metastasis status. (A) Overall survival and (B) recurrence-free survival of patients in the derivation cohort. (C) Overall survival and (D) recurrence-free survival of patients in the validation cohort. (E) Overall survival and (F) recurrence-free survival of patients in the entire cohort. pN0—pathological lymph node negative; pN + —pathological lymph node positive.